Parojinog, Jovil A.
HRN: 21-93-16 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/21/2022
CEFUROXIME 750MG (VIAL)
09/21/2022
09/27/2022
IV
750mg
Q8
T/C UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose Optimize Dose
Overall appropriateness: No Optimize Dose